Patents Assigned to IMAGNX, Inc.
  • Methods for metabolic imaging
    Patent number: 9034928
    Abstract: The present embodiments disclose the preparation of hyperpolarized 13C dialkyl succinate compounds and hyperpolarized 13C dialkyl fumarate compounds and their use in real time, in vivo metabolic imaging of the TCA cycle.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: May 19, 2015
    Assignee: IMAGNX, Inc.
    Inventors: Niki Zacharias Millward, Pratip Bhattacharya